While direct studies in MASLD are limited, chronic liver disease models show the upregulation of inhibitory receptors, such as PD-1 and TIM-3 on CD8+ T cells [57,58]. This evidence concerns the gene HAVCR2 and metabolic dysfunction-associated steatotic liver disease.